Method for Augmenting B Cell Depletion
AssigneeGenentech, Inc.
InventorsAndrew Chan, Qian Gong, Flavius Martin
Life of this patent
Estimating the term…
Abstract
The present invention provides methods of augmenting B cell depletion by promoting intravascular access of B cell subsets sequestered in lymphoid tissues rendering the B cells sensitive to killing mediated by the B cell depleting agent. One method of promoting intravascular access is by the use of integrin antagonists. Methods of treating B cell disorders by this approach is also provided.
Claims16
A method of augmenting B cell depletion in a mammal suffering from a B cell disorder, comprising administering to the mammal, one or more B cell mobilizing agents and a therapeutically effective amount of one or more B cell depleting agents, wherein the B cell mobilizing agent is an α4 integrin antagonist antibody, or a biologically active fragment thereof.
Dependencies are inferred from the claim text.